Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin‐converting enzyme inhibitors – a nationwide registry‐based cohort study-Reference-Cited by-同舟云学术

Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin‐converting enzyme inhibitors – a nationwide registry‐based cohort study

Published:2019-01-08 Issue:5 Volume:285 Page:553-561
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Rasmussen Eva Rye¹,Pottegård Anton²,Bygum Anette³,Buchwald Christian¹,Homøe Preben⁴,Hallas Jesper²

Affiliation:

1. Department of Otorhinolaryngology, Head & Neck Surgery and Audiology Rigshospitalet, University of Copenhagen Blegdamsvej 9B 2100 Copenhagen East Denmark

2. Clinical Pharmacology and Pharmacy University of Southern Denmark J.B. Winsløws Vej 19 5000 Odense C Denmark

3. Department of Dermatology and Allergy Center Odense University Hospital J.B. Winsløwsvej 4, Entrance 142 5000 Odense C Denmark

4. Department of Otorhinolaryngology and Maxillofacial Surgery Zealand University Hospital Lykkebaekvej 1 4600 Køge Denmark

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.12867

Reference33 articles.

1. Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema

2. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine

3. Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors

4. Angioedema due to angiotensin-converting enzyme inhibitors

5. Angioedema Related to Angiotensin-Converting Enzyme Inhibitors

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pharmacovigilance study assessing risk of angioedema with angiotensin receptor blockers using the US FDA Adverse Event Reporting System;Expert Opinion on Drug Safety;2024-08-19

2. Risk of drug-induced angioedema: a pharmacovigilance study of FDA adverse event reporting system database;Frontiers in Pharmacology;2024-07-16

3. A Case Report of a Diaphragmatic Defect Developing Into a Late-Presenting Congenital Diaphragmatic Hernia With Severe Respiratory Failure;Cureus;2024-07-07

4. Management of Chronic Heart Failure with Reduced Ejection Fraction;The Journal of the American Board of Family Medicine;2024-05

5. Five-Membered Nitrogen Heterocycles Angiotensin-Converting Enzyme (ACE) Inhibitors Induced Angioedema: An Underdiagnosed Condition;Pharmaceuticals;2024-03-10